BP

Brajesh Pal

Active Director Director DIN 08070012
DIN 08070012 First appointment Feb 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value •••• Premium profile

About Brajesh Pal

Data last updated:

Brajesh Pal is a Director at Medixiq Pharmaceuticals Private Limited (since 2018). The company operates in Trading. Medixiq Pharmaceuticals Private Limited reported revenue of ₹1.1 Lakh (FY 2020).

DIN 08070012
Primary Designation Director
Industry Trading
First Appointment 16 Feb 2018
Oldest Company Age 8 yrs
Largest company Medixiq Pharmaceuticals Private Limited · ₹1.1 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Feb 20182018₹1.1 Lakh (FY 2020)Active

Board colleagues of Brajesh Pal

NameDINCompanyDesignation
Mohit Pal08070013Medixiq Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medixiq Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Brajesh Pal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Brajesh Pal

Brajesh Pal currently holds 1 directorship: Medixiq Pharmaceuticals Private Limited (Director, since 16 Feb 2018, revenue ₹1.1 Lakh (FY 2020)).

Brajesh Pal was first appointed on 16 Feb 2018 as Director at Medixiq Pharmaceuticals Private Limited.

The current boards of Brajesh Pal's companies include Mohit Pal (Medixiq Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available